|
Notice:
|
|
Suspension of shipments during Golden Week Holidays: From 30 April to 14 May, deadline 17 April.
|
|
| NIG-RNAi Strains Detail |
| Request : Click the "Order" button to request for this stock |
|
| Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
| Stock ID |
12217R-1 |
| Symbol |
PpV |
Full Name |
Protein phosphatase V |
| CG No |
CG12217 |
Old CG No |
CG12217 |
| Synonyms |
DmPpV-6A, CG12217, PPV, PPPV6A, PPV 6A, PpV |
| Accession No (Link to NCBI) |
NM_078506.2 |
| Inserted Chr. |
ll |
| Insertional Mutation |
|
| Phenotype induced by Act5C-GAL4 at 28 degrees |
lethal |
| Map Viewer |
|
Reference
[Please submit your publication]
|
Park J, Lee J, Kim JH, Lee J, Park H, Lim C.
ZNF598 co-translationally titrates poly(GR) protein implicated in the pathogenesis of C9ORF72-associated ALS/FTD.
Nucleic Acids Res (2021) 49(19) 11294-11311
[
PubMed ID = 34551427
]
[
RRC reference
]
Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD.
Zyxin links fat signaling to the hippo pathway.
PLoS Biol (2011) 9(6) e1000624
[
PubMed ID = 21666802
]
[
RRC reference
]
|
| Comment |
|
| Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
| Primer Seq. 5' |
aaggcctacatggccggaccgAAATGCAAGTACCTGCCGGAG |
| Primer Seq. 3' |
aatctagaggtaccCGATCGATCGTCCTGATCTGG |
| Predicted Fragment Size |
500 |
| IR fragment full Seq |
0001 AAATGCAAGT ACCTGCCGGA GAACGAGCTG AAGAAGCTAT GCGAGATGGT CTGCGATATC
0061 CTCCTGGAGG AGAACGAACA TCCTGCCCGT GAGCACGCCC GTCACCGTTT GCGGTGACAT
0121 CNCATGGCCA GTTCTACGAC CTGGAGCAGC TGTTCCGCAC TGGAGGCCAG GTGCCGCNAT
0181 ACCAACTACA TATTCATGGG CGACTTCGTG GACAGGGGCT ACTACTCGCT GGAGACATTC
0241 ACCAGACTGC TCACGCTGAA GGCGCGCTTA TCCCAGCCGG ATCACCCTGC TGCGCGGCAA
0301 CCACGAGACG CGGCAGATCA CCAAGGTGTA CGGATTCTTT GACGAGTGCT TCAGCAAGTA
0361 CGGCAATGcC AATGGCTGGA AATACTGCTG CAAGGTCTTC GATTTGCTTA CCATCGCTGC
0421 CATCATCGAC GAGGAGGTGT TGTGCGTGCA CGGTGGCCTG AGTCCCGAGA TCATTACACT
0481 GGACCAGATC AGGACGATCG ATCG |
| in silico PCR Fragment |
0001 AAATGCAAGT ACCTGCCGGA GAACGAGCTG AAGAAGCTAT GCGAGATGGT CTGCGATATC
0061 CTCCTGGAGG AG-ACGAACA TCCTGCCCGT GAGCACGCCC GTCACCGTTT GCGGTGACAT
0121 C-CATGGCCA GTTCTACGAC CTGGAGCAGC TGTTCCGCAC TGGAGGCCAG GTGCCGC-AT
0181 ACCAACTACA TATTCATGGG CGACTTCGTG GACAGGGGCT ACTACTCGCT GGAGACATTC
0241 ACCAGACTGC TCACGCTGAA GGCGCGC-TA TCCCAGCCGG ATCACCCTGC TGCGCGGCAA
0301 CCACGAAACG CGGCAGATCA CCAAGGTGTA CGGATTCTTT GACGAGTGCT TCAGCAAGTA
0361 CGGCAATGCC AATGGCTGGA AATACTGCTG CAAGGTCTTC GATTTGCTTA CCATCGCTGC
0421 CATCATCGAC GAGGAGGTGT TGTGCGTGCA CGGTGGCCTG AGTCCCGAGA TCATTACACT
0481 GGACCAGATC AGGACGATCG ATCG |
| Assemble Data |
12217R-1.IR_full 1 AAATGCAAGTACCTGCCGGAGAACGAGCTGAAGAAGCTATGCGAGATGGTCTGCGATATC 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12217R-1.in silico 1 AAATGCAAGTACCTGCCGGAGAACGAGCTGAAGAAGCTATGCGAGATGGTCTGCGATATC 60
12217R-1.IR_full 61 CTCCTGGAGGAGAACGAACATCCTGCCCGTGAGCACGCCCGTCACCGTTTGCGGTGACAT 120
|||||||||||| |||||||||||||||||||||||||||||||||||||||||||||||
12217R-1.in silico 61 CTCCTGGAGGAG-ACGAACATCCTGCCCGTGAGCACGCCCGTCACCGTTTGCGGTGACAT 120
12217R-1.IR_full 121 CNCATGGCCAGTTCTACGACCTGGAGCAGCTGTTCCGCACTGGAGGCCAGGTGCCGCNAT 180
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||| ||
12217R-1.in silico 121 C-CATGGCCAGTTCTACGACCTGGAGCAGCTGTTCCGCACTGGAGGCCAGGTGCCGC-AT 180
12217R-1.IR_full 181 ACCAACTACATATTCATGGGCGACTTCGTGGACAGGGGCTACTACTCGCTGGAGACATTC 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12217R-1.in silico 181 ACCAACTACATATTCATGGGCGACTTCGTGGACAGGGGCTACTACTCGCTGGAGACATTC 240
12217R-1.IR_full 241 ACCAGACTGCTCACGCTGAAGGCGCGCTTATCCCAGCCGGATCACCCTGCTGCGCGGCAA 300
||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||
12217R-1.in silico 241 ACCAGACTGCTCACGCTGAAGGCGCGC-TATCCCAGCCGGATCACCCTGCTGCGCGGCAA 300
12217R-1.IR_full 301 CCACGAGACGCGGCAGATCACCAAGGTGTACGGATTCTTTGACGAGTGCTTCAGCAAGTA 360
|||||| |||||||||||||||||||||||||||||||||||||||||||||||||||||
12217R-1.in silico 301 CCACGAAACGCGGCAGATCACCAAGGTGTACGGATTCTTTGACGAGTGCTTCAGCAAGTA 360
12217R-1.IR_full 361 CGGCAATGCCAATGGCTGGAAATACTGCTGCAAGGTCTTCGATTTGCTTACCATCGCTGC 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12217R-1.in silico 361 CGGCAATGCCAATGGCTGGAAATACTGCTGCAAGGTCTTCGATTTGCTTACCATCGCTGC 420
12217R-1.IR_full 421 CATCATCGACGAGGAGGTGTTGTGCGTGCACGGTGGCCTGAGTCCCGAGATCATTACACT 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12217R-1.in silico 421 CATCATCGACGAGGAGGTGTTGTGCGTGCACGGTGGCCTGAGTCCCGAGATCATTACACT 480
12217R-1.IR_full 481 GGACCAGATCAGGACGATCGATCG 504
||||||||||||||||||||||||
12217R-1.in silico 481 GGACCAGATCAGGACGATCGATCG 504
|
| Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
| cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
| 100 |
482 |
0 |
0 |
0 |
NM_078506.2 |
CG12217-RA (PpV), mRNA |
| 1.03 |
5 |
9 |
11 |
24 |
NM_167523.2 |
CG9819-RA, transcript variant A (CanA-14F), mRNA |
| 1.03 |
5 |
9 |
11 |
24 |
NM_167524.2 |
CG9819-RB, transcript variant B (CanA-14F), mRNA |
| 0.82 |
4 |
2 |
16 |
16 |
NM_080198.2 |
CG5650-RA (Pp1-87B), mRNA |
| 0.62 |
3 |
9 |
13 |
25 |
NM_078649.2 |
CG9842-RA (Pp2B-14D), mRNA |
| 0 |
0 |
5 |
2 |
6 |
NM_176368.1 |
CG6571-RD, transcript variant D (rdgC), mRNA |
| 0 |
0 |
5 |
2 |
6 |
NM_176367.1 |
CG6571-RC, transcript variant C (rdgC), mRNA |
| 0 |
0 |
5 |
2 |
6 |
NM_176366.1 |
CG6571-RB, transcript variant B (rdgC), mRNA |
| 0 |
0 |
5 |
2 |
6 |
NM_080490.3 |
CG6571-RA, transcript variant A (rdgC), mRNA |
| 0 |
0 |
4 |
20 |
16 |
NM_079861.2 |
CG1455-RA (CanA1), mRNA |
| 0 |
0 |
4 |
19 |
65 |
NM_057457.3 |
CG7109-RA (mts), mRNA |
| 0 |
0 |
4 |
4 |
15 |
NM_080208.2 |
CG8822-RA (PpD6), mRNA |
| 0 |
0 |
3 |
12 |
7 |
NM_133004.1 |
CG8211-RA (CG8211), mRNA |
| 0 |
0 |
3 |
7 |
17 |
NM_079760.2 |
CG6593-RA (Pp1alpha-96A), mRNA |
| 0 |
0 |
3 |
4 |
3 |
NM_168496.1 |
CG4300-RA, transcript variant A (CG4300), mRNA |
| 0 |
0 |
3 |
4 |
3 |
NM_140308.2 |
CG4300-RB, transcript variant B (CG4300), mRNA |
| 0 |
0 |
3 |
2 |
2 |
NM_137849.2 |
CG3751-RA (RpS24), mRNA |
| 0 |
0 |
3 |
2 |
2 |
NM_205956.1 |
CG33302-RA (CG33302), mRNA |
| 0 |
0 |
2 |
5 |
3 |
NM_165580.2 |
CG8726-RA, transcript variant A (CG8726), mRNA |
| 0 |
0 |
2 |
5 |
3 |
NM_136497.3 |
CG8726-RB, transcript variant B (CG8726), mRNA |
| 0 |
0 |
2 |
5 |
2 |
NM_144062.1 |
CG11373-RA (CG11373), mRNA |
| 0 |
0 |
2 |
2 |
6 |
NM_143379.2 |
CG1647-RA (CG1647), mRNA |
| 0 |
0 |
1 |
32 |
38 |
NM_080064.2 |
CG32505-RA, transcript variant A (Pp4-19C), mRNA |
| 0 |
0 |
1 |
32 |
38 |
NM_167703.3 |
CG32505-RE, transcript variant E (Pp4-19C), mRNA |
| 0 |
0 |
1 |
9 |
10 |
NM_079999.2 |
CG2096-RB, transcript variant B (flw), mRNA |
| 0 |
0 |
1 |
9 |
10 |
NM_167229.1 |
CG2096-RA, transcript variant A (flw), mRNA |
| 0 |
0 |
1 |
4 |
5 |
NM_170139.1 |
CG31132-RA (BRWD3), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_135236.2 |
CG10806-RB, transcript variant B (CG10806), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_079713.2 |
CG6376-RA, transcript variant A (E2f), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_164717.1 |
CG10806-RA, transcript variant A (CG10806), mRNA |
|
|
|
